arginine vasopressin has been researched along with pirenzepine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bianconi, L; Caiazza, A; Capretti, L; Chiodera, P; Coiro, V; Fagnoni, F; Schianchi, L; Speroni, G; Volpi, R | 1 |
| Martin, DS; McNeill, JR | 1 |
| Butturini, U; Chiodera, P; Coiro, V; Delsignore, R; Gnudi, A; Volpi, R | 1 |
| Franco, W; Leite, RS | 1 |
| Abe, K; Egawa, T; Fujii, M; Fujiwara, M; Inada, K; Iwasaki, K; Matsumoto, Y; Mishima, K; Tsukikawa, H | 1 |
| Abe, K; Egashira, N; Fujiwara, M; Inada, K; Iwasaki, K; Matsumoto, Y; Mishima, K; Miura, I; Tsukikawa, H | 1 |
7 other study(ies) available for arginine vasopressin and pirenzepine
| Article | Year |
|---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Muscarinic cholinergic, but not serotoninergic mediation of arginine vasopressin response to metoclopramide in man.
Topics: Adult; Arginine Vasopressin; Atropine; Dose-Response Relationship, Drug; Humans; Ketanserin; Kinetics; Male; Metergoline; Metoclopramide; Pirenzepine; Receptors, Muscarinic; Receptors, Serotonin | 1989 |
Pressor and intestinal vascular bed responses to vasopressin after cholinergic blockade.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Cats; Dose-Response Relationship, Drug; Electric Conductivity; Heart Rate; Intestines; N-Methylscopolamine; Pirenzepine; Regional Blood Flow; Scopolamine Derivatives; Splanchnic Circulation; Vasopressins | 1988 |
Nicotinic-cholinergic involvement in arginine-vasopressin response to insulin-induced hypoglycemia in normal men.
Topics: Adult; Arginine Vasopressin; Benzodiazepinones; Humans; Hypoglycemia; Insulin; Male; Parasympatholytics; Pirenzepine; Receptors, Cholinergic; Receptors, Muscarinic; Receptors, Nicotinic; Trimethaphan | 1986 |
Effects of cholinergic agents on the vasopressin-mediated water transport in the isolated toad bladder.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Arginine Vasopressin; Atropine; Biological Transport; Bufo marinus; Calcium; Calcium Channel Blockers; Carbachol; Cholinergic Agonists; Cholinergic Antagonists; In Vitro Techniques; Isotonic Solutions; Lanthanum; Osmolar Concentration; Piperidines; Pirenzepine; Urinary Bladder; Vasoconstrictor Agents; Water | 2001 |
Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium Channel Blockers; Dose-Response Relationship, Drug; Hemicholinium 3; Hippocampus; Hormone Antagonists; Injections, Intraventricular; Male; Maze Learning; Memory; Memory Disorders; Neurotransmitter Uptake Inhibitors; Nicardipine; Peptide Fragments; Pirenzepine; Rats; Rats, Wistar; Receptors, Vasopressin; Scopolamine | 2001 |
Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinases; Cholinergic Antagonists; Maze Learning; Memory; Microdialysis; Nicardipine; Nootropic Agents; Oligopeptides; Pirenzepine; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Receptors, Vasopressin; Scopolamine | 2003 |